These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33223734)

  • 41. Evaluation of platelet-rich plasma vs intralesional steroid in treatment of alopecia areata.
    Albalat W; Ebrahim HM
    J Cosmet Dermatol; 2019 Oct; 18(5):1456-1462. PubMed ID: 31074201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dermoscopic findings in radiation-induced alopecia after angioembolization.
    Cho S; Choi MJ; Lee JS; Zheng Z; Kim DY
    Dermatology; 2014; 229(2):141-5. PubMed ID: 25171463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dermoscopy findings of alopecia areata in an African-American patient.
    de Moura LH; Duque-Estrada B; Abraham LS; Barcaui CB; Sodre CT
    J Dermatol Case Rep; 2008 Dec; 2(4):52-4. PubMed ID: 21886714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictive model for immunotherapy of alopecia areata with diphencyprone.
    Wiseman MC; Shapiro J; MacDonald N; Lui H
    Arch Dermatol; 2001 Aug; 137(8):1063-8. PubMed ID: 11493099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized controlled trial to compare the effectiveness and safety of low dose dexamethasone oral mini-pulse versus diphenylcyclopropenone contact sensitisation in severe pediatric alopecia areata.
    Mahajan R; Daroach M; Handa S; De D
    Dermatol Ther; 2022 Nov; 35(11):e15810. PubMed ID: 36086930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience.
    El Khoury J; Abd-el-Baki J; Succariah F; Abbas O; Kibbi AG; Kurban M
    Int J Dermatol; 2013 Dec; 52(12):1551-6. PubMed ID: 24134785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and dermatoscopic patterns of alopecia areata: a tertiary care centre experience.
    Hegde SP; Naveen KN; Athanikar SB; Reshme P
    Int J Trichology; 2013 Jul; 5(3):132-6. PubMed ID: 24574691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alopecia areata in children: treatment with diphencyprone.
    Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
    Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diphenylcyclopropenone and platelet-rich plasma in the management of severe or recalcitrant alopecia areata.
    Abd El-Magid WM; Mohamed RA; Elsharkawy RE
    J Cosmet Dermatol; 2023 Nov; 22(11):2971-2981. PubMed ID: 37313640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic Effect of Superficial Cryotherapy on Alopecia Areata: A Prospective, Split-scalp Study in Patients with Multiple Alopecia Patches.
    Jun M; Lee WS
    Ann Dermatol; 2017 Dec; 29(6):722-727. PubMed ID: 29200760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
    Brown L; Skopit S
    J Drugs Dermatol; 2018 Aug; 17(8):914-917. PubMed ID: 30124734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study.
    Çerman AA; Solak SS; Altunay İ; Küçükünal NA
    J Drugs Dermatol; 2015 Jun; 14(6):616-20. PubMed ID: 26091388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinico-Epidemiological Profile of Childhood Alopecia Areata Along with Dermoscopic Correlation: A Cross-Section, Observational Study.
    Bhardwaj P; Basu D; Podder I; Gharami RC
    Indian Dermatol Online J; 2021; 12(2):250-257. PubMed ID: 33959521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity.
    Sayed Mahmoud Marie RE; Abd El-Fadeel NM; El-Sayed Marei Y; Atef LM
    Dermatol Res Pract; 2022; 2022():5004642. PubMed ID: 35300124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alopecia Areata in a Dog: Clinical, Dermoscopic and Histological Features.
    Scarampella F; Roccabianca P
    Skin Appendage Disord; 2018 Apr; 4(2):112-117. PubMed ID: 29765971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata.
    Luk NM; Chiu LS; Lee KC; Chau CT; Lee VW; Chang M; Lam YK; Lee HC
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e400-5. PubMed ID: 23057682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alopecia areata predictive score: A new trichoscopy-based tool to predict treatment outcome in patients with patchy alopecia areata.
    Waśkiel-Burnat A; Rakowska A; Sikora M; Olszewska M; Rudnicka L
    J Cosmet Dermatol; 2020 Mar; 19(3):746-751. PubMed ID: 31301100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Follicular microhemorrhage: a unique dermoscopic sign for the detection of coexisting trichotillomania in alopecia areata.
    Ise M; Amagai M; Ohyama M
    J Dermatol; 2014 Jun; 41(6):518-20. PubMed ID: 24815359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Abbott F; Tron V
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):729-35. PubMed ID: 7901248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.